Nanoparticle-containing, spray can aerosol: characterization, exposure assessment, and inhalation chamber design.
Authors
Chen BT; Afshari A; Stone S; Jackson M; McKinney W; Schwegler-Berry D; Frazer DG; Castranova V; Thomas TA
Source
Proceedings of the AAAR 29th Annual Conference, October 25-29, 2010, Portland, Oregon. Mount Laurel, NJ: American Association for Aerosol Research, 2010 Oct; :110
This report describes the methods developed for reliable characterization of a nanoparticle-containing aerosol released from a consumer spray product. A well-controlled environment was employed to simulate an indoor setting for conducting spray applications in a human exposure scenario. Results indicate that, while aerosol droplets were large with a count median diameter of 22 um during spraying, the final aerosol contained primarily solid TiO2 particles with a diameter of 75 nm. This size reduction was due to the impaction of the droplets on the surface and the fast drying of the aerosol during sampling. In the breathing zone, the TiO2 aerosol, containing primarily single particles (> 90%), had a mass concentration of 3.4 mg/m3, or 1.6 x 105 particles/cm3, with a nanoparticle fraction limited to 170 ug/m3, or 1.2 x 105 particles/cm3. This information was used to estimate the pulmonary dose in an average male adult (= 0.075 ug TiO2 per m2 alveolar epithelium per minute) as well as in a rat (= 0.03 ug TiO2), and, consequently, was used to design an animal inhalation exposure study. An inhalation exposure system consisting of a computer-controlled solenoid ''finger'' for generating spray can aerosol was developed and evaluated. The results demonstrate a great similarity in this solenoid ''finger''-dispersed aerosol compared to the aerosol occurring in the human exposure scenario. The next step would be to initiate an inhalation toxicological study to obtain information on dose-response relationships and to use it to establish a No Effect Exposure Level for setting guidelines for this consumer product.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.